CARPHA cautions against the use of adult vaccine for children under 11
The Pfizer-BioNTech vaccine could be approved for use in children aged 12 and under within months by the US Food and Drug Administration (Photo courtesy NJ.com) CARPHA Statement on the Administration of Pfizer Vaccines to Children Aged 5 to 11 Port of Spain, Trinidad and Tobago, 9...